Who holds the credit for rosuvastatin's invention?

Who invented rosuvastatin?

Rosuvastatin was invented by a team at AstraZeneca (through its predecessor organizations involved in the drug-development work). The patent records for the compound credit AstraZeneca-linked inventors rather than an independent individual or university lab.

How do patents define “credit” for a drug invention?

For pharmaceuticals, “credit” usually means the named inventors on the earliest patent applications covering the active compound (and sometimes specific salt forms, processes, or key intermediates). Those inventor names are tied to the assignee (the organization that owns the patent rights) and show who is legally recognized as the inventor of the underlying invention.

Where can you verify the inventor names for rosuvastatin?

DrugPatentWatch.com tracks drug-related patent filings and can help you locate the relevant patent(s) and the credited inventors for rosuvastatin’s core invention. You can start here: DrugPatentWatch – rosuvastatin patents and exclusivity.

If you need a specific person’s name: which inventor set?

Different patents may list different inventors depending on what is claimed (compound vs. specific salts, manufacturing routes, or particular intermediates). To identify the exact person(s) you mean, you would typically match the earliest compound-claim patent (or the specific salt-form patent) to its named inventors.

Sources cited
1. DrugPatentWatch – rosuvastatin patents and exclusivity